Santhera Pharmaceuticals Holding AG Logo

Santhera Pharmaceuticals Holding AG (SPHDF)

OTC

Currency in USD
18.30
0.00 (0.00%)

Closed

Oct 14, 2026

Day's Range

18.30
18.30

52 wk Range

12.28
23.25

Overview - SPHDF - Santhera Pharmaceuticals Holding AG

Key Statistics

Valuation

Enterprise Value

329.05M

P/E (Trailing)

‪2.52‬

Price / Sales (TTM)

‪2.76‬

EV / EBITDA

‪-75.35‬

Profitability

Gross Margin

‪86.33%‬

Profit Margin

‪-31.45%‬

Operating Margin

‪-13.58%‬

Return on Assets

‪-3.92%‬

Return on Equity

‪416.68%‬

Ownership

Shares Outstanding

13.39M

Float

12.63M

Held by Insiders

‪11.15%‬

Held by Institutions

‪15.93%‬

Price stats

Beta

‪-0.39‬

50-Day Avg

‪21.25‬

200-Day Avg

‪20.56‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

News Teaser - SPHDF - Santhera Pharmaceuticals Holding AG

News & Analysis

View all news

Market Cap - SPHDF - Santhera Pharmaceuticals Holding AG

Peers - SPHDF - Santhera Pharmaceuticals Holding AG

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - SPHDF - Santhera Pharmaceuticals Holding AG

About

Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company headquartered in Pratteln, Switzerland, dedicated to the research, development, and commercialization of innovative medicines for patients with rare and debilitating diseases. The company primarily targets unmet medical needs in…

SectorHealthcare
IndustryBiotechnology
Employees93
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.